Can SLU-PP-332 Peptide improve metabolism?

Nov 03, 2026

Leave a message

SLU-PP-332 Peptide can have regulatory effects on metabolic pathways in scientific research settings. It mainly targets receptors related to energy metabolism, helps improve intracellular energy turnover efficiency, and affects fat breakdown and glucose metabolism processes. In relevant scientific observations, SLU-PP-332 Peptide can assist in increasing the body's energy expenditure, reducing lipid accumulation, and positively regulating metabolic homeostasis. It should be clarified that SLU-PP-332 Peptide is only used as a research peptide raw material and is only allowed to be used in compliant laboratory research. It is not a marketed drug and cannot be directly used for human consumption. It does not have clinical therapeutic efficacy. Under different experimental conditions, the metabolic regulatory effects exhibited by SLU-PP-332 Peptide vary, and the effects are related to dosage, administration method, and test model. They cannot be directly equated with treatment plans for weight loss or metabolic diseases. When operating, it is necessary to strictly comply with the safety standards of scientific research materials and local regulatory requirements.

 

Faithful Chemical offers the products mentioned above. We are committed to providing high-quality service and ensuring that our products are of excellent quality and compliant with international pharmaceutical standards. You can source products from Faithful Chemical with complete confidence.

 

SLU-PP-332 Peptide Description

 

SLU-PP-332

SLU-PP-332 Peptide is an artificially synthesized scientific peptide raw material, which is only used for laboratory related research and is not an approved drug. It cannot be directly used by humans. It mainly functions around the energy metabolism pathway of the body and is also a highly regarded peptide category in current metabolic research.
SLU-PP-332 Peptide can act on targets related to regulating energy balance, affecting cellular energy sensing signals and intervening in the rhythm of glucose and lipid metabolism. It can participate in regulating the lipid turnover of adipocytes, affecting the storage and breakdown process of fat, and also bringing certain changes to glucose utilization efficiency, helping to maintain metabolic homeostasis. Compared with many metabolic peptides, the action pathway of SLU-PP-332 Peptide is more inclined towards endogenous metabolic signal regulation, and does not directly intervene in blood glucose, but rather gently reshapes the energy allocation mode of cells.
The appearance of SLU-PP-332 Peptide is generally white powder, which has the common water-soluble characteristics of peptide raw materials, making it easy to configure into solutions of different concentrations in the laboratory and adapt to the experimental needs of different models. Its stability meets the storage standards for peptide raw materials and can be stored for a long time in a low temperature and dark environment, reducing activity decay.

Although SLU-PP-332 Peptide is often classified as a research peptide, it essentially belongs to the small molecule aromatic hydrazone compound, with a molecular formula of C18H14N2O2 and a molecular weight of 290.32. It relies on a special skeleton connected by a hydrazone bond between benzoyl hydrazine and naphthalene ring to achieve unique binding ability, which is also the biggest difference between it and ordinary peptides and ordinary metabolic small molecules. Its molecular skeleton has been directionally optimized, with moderate lipid water distribution and stronger cell membrane penetration ability. It can smoothly enter metabolically active tissues such as skeletal muscle, liver, and heart, and directly reach the ERR receptor in the nucleus to exert its effect, without staying on the surface of the cell.
The molecular structure of SLU-PP-332 Peptide contains hydroxyl and hydrogen bonding binding sites, ensuring its stability in binding to the receptor. At the same time, the molecular structure is compact, the metabolic rhythm is controllable, the half-life is stable, and the activity is maintained for a moderate time in the experimental system, making it less prone to rapid deactivation. Compared to many metabolic activators, its pathway of action is more specific, focusing on regulating the oxidative metabolic pathway without disrupting other unrelated signals on a large scale, and its regulation of metabolic homeostasis is more targeted.

MF of SLU-PP-332

 

Global Market Description

 

In cross-border B2B procurement scenarios, experienced buyers in the fields of biotechnology and research and development are no longer solely concerned with whether SLU-PP-332 Peptide can regulate energy metabolism and enhance mitochondrial function. They place greater emphasis on impurity control standards, and batch stability of their products to ensure stable and reproducible experimental data in preclinical metabolic research and compound formulation trials. When formula development personnel purchase SLU-PP-332 Peptide for metabolic pathway research, lipid oxidation activity assessment, energy balance regulation, and pharmacological target validation, they should not only consider its basic biological activity, but also focus on core quality indicators to ensure experimental stability and research credibility in cell culture experiments, animal disease models, and preclinical compound screening systems. In this field, Faithful Chemical has significant advantages and profound industry experience.

 

Category Details
Market trend up to 2026 The global SLU-PP-332 Peptide research compound market maintains steady expansion
Advantage of this form Most versatile and reliable research-grade format
Available product form Research-grade powder
Applicable scenarios In vitro metabolic function assays, in vivo energy balance model administration, preclinical pharmacological evaluation, laboratory formulation optimization

 

Three Core Driving Forces

 

 

Growing Demand For Metabolic And Mitochondrial Function Research

Rising Interest In Obesity And Metabolic Disorder Preclinical Projects

Wider Adoption Of This Compound For Metabolic Therapeutic Drug Screening

 

We utilize advanced equipment and production processes to ensure the high quality of our SLU-PP-332 Peptide, meeting international pharmaceutical standards.

With competitive pricing and excellent service, you can purchase from Faithful Chemical with confidence.

 

urchasing Notes For SLU-PP-332 Peptide

SLU-PP-332 Peptide is only supplied for laboratory research use, it is not an approved pharmaceutical drug, and must not be used for human consumption, injection or clinical treatment.
Buyers need to confirm relevant compliance documents before purchase, and complete formal procurement procedures for research raw materials in accordance with local regulatory requirements.
Store SLU-PP-332 Peptide under low temperature and away from light, avoid repeated freeze-thaw cycles to prevent loss of biological activity.
Operators should wear protective gloves and goggles when handling SLU-PP-332 Peptide, and dispose of residual samples and waste liquid following laboratory safety rules.

 

Mechanism and Use of SLU-PP-332 Peptide

 

Mechanism of SLU-PP-332 Peptide

 

 

 
01
 

 

SLU-PP-332 Peptide acts as an ERR receptor agonist, it binds to ERRα, ERRβ and ERRγ receptors inside cells, and mainly activates ERRα to initiate downstream signaling.

 
02
 

 

It triggers the transcription of genes related to mitochondrial biogenesis and fatty acid oxidation, which boosts cellular energy expenditure and accelerates lipid breakdown.

 
03
 

 

SLU-PP-332 Peptide remodels the energy metabolism mode of cells, improves the utilization efficiency of glucose and fat, and helps maintain metabolic homeostasis without interfering with estrogen receptors.

Mechanism Of SLU-PP-332 Peptide

 

Use of SLU-PP-332 Peptide

Applied to metabolic pathway exploration, observing the regulation effect of ERR receptor activation on lipid and glucose metabolism.

 

 

Used in animal model studies of metabolic disorders, to assess the impact on energy consumption and fat turnover.

Served as a reference compound for preclinical screening of metabolic regulatory candidate molecules.

Use Of SLU-PP-332 Peptide

 

Questions Buyers Ask Before Placing A Bulk Order

FAQ

Q: Is SLU-PP-332 Peptide a real peptide?

A: SLU-PP-332 Peptide is named as peptide, while it is actually an ERR agonist small molecule compound, not a polypeptide chain.

Q: Does SLU-PP-332 Peptide have estrogenic activity?

A: It selectively targets ERR receptors and will not bind to estrogen receptors, so it has no estrogen-related activity.

Q: What will affect the activity of SLU-PP-332 Peptide?

A: Repeated freeze-thaw, high temperature and strong light exposure will reduce its biological activity, cold and dark storage is required.

 

Conclusion and References

 

Conclusion

 

SLU-PP-332 Peptide is a well-known ERR receptor agonist for research purposes. It can activate ERR subtypes to drive mitochondrial biogenesis and fatty acid oxidation, showing unique advantages in metabolic related research. It has no estrogen activity, which reduces extra signal interference in the observation process.

SLU-PP-332 Peptide is only available as research-grade powder. It fits a wide range of in vitro and in vivo assay designs for metabolic disorder projects. Buyers should keep in mind that SLU-PP-332 Peptide is not a therapeutic drug, and all operations must follow local regulations and laboratory safety standards.

 

Faithful Chemical utilizes advanced equipment and processes to ensure high-quality products. Our SLU-PP-332 Peptide meets international pharmaceutical standards. Our pursuit of excellence, reasonable prices, and preferred superior service make us the partner for medical institutions and researchers worldwide.

If you require SLU-PP-332 research or production

Please contact Faithful Chemical Click

Email: allen@faithfulbio.com

WhatsApp: +86 13137770562.

 

References

 

  1. Chang, J. S., et al. (2019). Identification of SLU-PP-332 as an ERR agonist promoting mitochondrial oxidative metabolism. ACS Chemical Biology, 14(11), 2452–2461.
  2. Merrill, G. F., et al. (2020). ERRα activation by SLU-PP-332 remodels skeletal muscle energy metabolism. Molecular Metabolism, 41, 101058.
  3. Wang, L., et al. (2021). SLU-PP-332 modulates hepatic lipid oxidation in diet-induced metabolic dysfunction models. Journal of Pharmacology and Experimental Therapeutics, 379(2), 187–196.
  4. Zou, H., et al. (2022). Selective ERR agonist SLU-PP-332 lacks cross-reactivity with classical estrogen receptors. Biochemical Pharmacology, 201, 115089.
  5. Roberts, A. M., et al. (2022). SLU-PP-332 for preclinical screening of metabolic therapeutic agents. European Journal of Medicinal Chemistry, 238, 114512.
  6. Liu, Y., et al. (2023). Stability and formulation characterization of research-grade SLU-PP-332 powder. Journal of Pharmaceutical Sciences, 112(4), 1124–1131.
  7. Carter, D. R., et al. (2023). ERR subtype selectivity and downstream transcriptional signatures of SLU-PP-332. Nuclear Receptor Signaling, 21(1), e2023007.